trial · primary record
TTRNA-DC vaccines with GM-CSF
Recurrent Oligodendroglioma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2028-06 |
| Primary endpoint | Prevalence of enrolled subject who receive qualified immunotherapy investigational product. |
| Registry ID | NCT06254326 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:03.014Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06254326
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.